Skip to content
Esta página está disponible en españolCambiar →

SEC filings · updated every 10 minutes

At the SEC on Thursday, November 12

Thursday, November 12, 2026 · 224 filings · latest: 20:43 ET

From the companies the site's managers follow: those held by 300+ 13F filers, or 30+ with concentrated managers or well-known investors. Form 144 notices from $1M and insider purchases from $100,000.

Companies with the most concentrated managers that filed that day

Filings of the day

224 filings from 196 companies

  • Hudson Pacific Properties

    HPP2 filings
    • 20:43 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      Jon E Bortz (director) bought 75,000 shares for $680,112 (avg. $9.07).

    • 20:43 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      Victor J Coleman (Chief Executive Officer) bought 20,000 shares for $182,000 (avg. $9.10).

    On GestorLens

    • 3 concentrated managers (+1 this quarter)
    • 99 13F filers
    GestorLens profile
  • EquipmentShare.com

    EQPT2 filings
    • 18:34 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      Jabbok Schlacks (Founder & CEO) bought 16,212 shares for $249,989 (avg. $15.42).

    • 17:10 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      W Bryan Hill (director) bought 40,000 shares for $554,116 (avg. $13.85).

    On GestorLens

    • 62 13F filers
    • 3 insiders bought in 180 days ($4.3M)
    • 1 13D filings in the last year

    Well-known investors: Tiger Global

    GestorLens profile
  • Crocs

    CROX
    • 18:34 ETPlanned insider salesSEC Form 144/A

      Amended notice of proposed sale (Form 144)

      Notice of proposed sale: Ronald Frasch (director) may sell up to 15,000 shares (~$2.3 million) on or about October 30, 2026.

    On GestorLens

    • 6 concentrated managers
    • 266 13F filers
    • 2 insiders bought in 180 days ($612,569)

    Well-known investors: Li Lu, David Einhorn

    GestorLens profile
  • Brookdale Senior Living

    BKD
    • 18:29 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      C Christian Winkle (director) bought 40,000 shares for $358,068 (avg. $8.95).

    On GestorLens

    • 3 concentrated managers (+2 this quarter)
    • 124 13F filers
    GestorLens profile
  • Bloomin’ Brands

    BLMN
    • 18:16 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      Mike Spanos (CEO) bought 50,000 shares for $502,000 (avg. $10.04).

    On GestorLens

    • 106 13F filers
    • 1 13D filings in the last year

    Well-known investors: Starboard Value

    GestorLens profile
  • Capri Holdings

    CPRI2 filings
    • 18:11 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Jenna Hendricks (officer) may sell up to 63,725 shares (~$1.3 million, 0.06% of shares outstanding) on or about November 12, 2026.

    • 06:03 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      Company headline: “Capri Holdings Limited Announces CEO Succession Plan”

      Also: Regulation FD disclosure

      From the filing
      On November 10, 2026, the Board of Directors (the “Board”) of Capri Holdings Limited (the “Company”) approved the Company’s entry into an employment agreement with Justin Boxford (the “Employment Agreement”) appointing Mr. Boxford as Chief Executive Officer of the Company and appointed Mr. Boxford as a member of the Board, each effective as of January 4, 2027 (the “Effective Date”).

    On GestorLens

    • 161 13F filers

    Well-known investors: David Einhorn

    GestorLens profile
  • Hagerty

    HGTY2 filings
    • 18:09 ET5%+ stakesSEC Schedule 13D/A

      Change in a 5%+ stake with activist intent

      Hagerty Holding updated its stake: 51.4% (144,414,656 shares) (active, 13D) as of November 11, 2026.

      Filed by: Hagerty Holding Corp.

    • 16:30 ETDeals and acquisitionsSEC 8-K 1.01

      Entry into a material agreement

      Company headline: “Pricing of its Upsized Secondary Offering of Class A Common Stock”

      Also: Other events

      From the filing
      On November 10, 2026, Hagerty, Inc. (the “Company”), The Hagerty Group, LLC, and Hagerty Holding Corp. (the “Selling Stockholder”) entered into an underwriting agreement (the “Underwriting Agreement”) with J.P.

    On GestorLens

    • 64 13F filers
    • 1 insider bought in 180 days ($99,370)
    • 2 13D filings in the last year

    Well-known investors: Markel Group

    GestorLens profile
  • Matador Resources

    MTDR
    • 18:07 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      Joseph Wm Foran (Chairman and CEO) bought 2,500 shares for $123,225 (avg. $49.29).

    On GestorLens

    • 4 concentrated managers (+1 this quarter)
    • 278 13F filers
    • 10 insiders bought in 180 days ($2.5M)
    GestorLens profile
  • Motorola Solutions

    MSI
    • 17:28 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Gregory Q Brown (officer) may sell up to 40,500 shares (~$21.5 million) on or about November 12, 2026.

    On GestorLens

    • 7 concentrated managers (+1 this quarter)
    • 960 13F filers
    GestorLens profile
  • Host Hotels & Resorts

    HST
    • 17:27 ETDeals and acquisitionsSEC 8-K 1.01

      Entry into a material agreement

      Also: Other events

      From the filing
      Substantially concurrently with the Company’s entry into the Distribution Agreement, the Company terminated its existing distribution agreement, dated as of May 31, 2023, among the Company and the agents, forward sellers and forward purchasers party thereto (as amended on May 27, 2026, the “Prior Distribution Agreement”), in accordance with the terms of the Prior Distribution Agreement.

    On GestorLens

    • 1 concentrated managers (-1 this quarter)
    • 454 13F filers
    GestorLens profile
  • HF Sinclair

    DINO
    • 17:17 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      Steve Ledbetter joins the board, effective November 10, 2026.

      From the filing
      On November 10, 2026, the Board of Directors (the “Board”) of HF Sinclair Corporation (the “Corporation”) expanded the size of the Board from ten to eleven members and appointed Steve Ledbetter to the Board, effective as of November 10, 2026.

    On GestorLens

    • 4 concentrated managers
    • 509 13F filers
    • 2 insiders bought in 180 days ($3.5M)
    • 1 13D filings in the last year

    Well-known investors: Semper Augustus

    GestorLens profile
  • Atlassian

    TEAM
    • 17:16 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      Michael Cannon-Brookes (CEO, Co-Founder) bought 13,400 shares for $2.0 million (avg. $150.30).

    On GestorLens

    • 1 concentrated managers (-1 this quarter)
    • 518 13F filers

    Well-known investors: Soros Fund

    GestorLens profile
  • Vista Gold

    VGZ
    • 17:10 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q3 2026 results: loss per share of $0.05.

      Company headline: “NYSE American and TSX Stock Exchanges”

      From the company's release
      Vista reported a consolidated net loss of $6.4 million, or $0.05 per common share, for the quarter ended September 30, 2026, compared to a consolidated net loss of $0.7 million, or $0.01 per common share, for the quarter ended September 30, 2025.

    On GestorLens

    • 56 13F filers

    Well-known investors: Markel Group

    GestorLens profile
  • Akamai Technologies

    AKAM
    • 17:05 ETDeals and acquisitionsSEC 8-K 1.01

      Entry into a material agreement

      Also: New direct financial obligation; Unregistered sale of equity; Regulation FD disclosure

      From the filing
      On November 12, 2026, Akamai Technologies, Inc. (“Akamai”) completed its previously announced offering of 1.00% Convertible Senior Notes due November 15, 2028 (the “2028 Notes”) and 1.00% Convertible Senior Notes due November 15, 2031 (the “2031 Notes” and, together with the 2028 Notes, the “Notes”).

    On GestorLens

    • 4 concentrated managers
    • 453 13F filers
    GestorLens profile
  • Flagstar Bank, National Association

    FLG
    • 17:01 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      Joseph M Otting (Exec Chairman and CEO) bought 47,324 shares for $496,429 (avg. $10.49).

    On GestorLens

    • 3 concentrated managers
    • 202 13F filers
    • 1 insider bought in 180 days ($101,400)

    Well-known investors: Soros Fund

    GestorLens profile
  • Charles Schwab

    SCHW
    • 16:52 ETOtherSEC 8-K 8.01

      Other events

      From the filing
      On November 12, 2026, The Charles Schwab Corporation (“CSC”) issued $300,000,000 aggregate principal amount of Floating Rate Notes due 2030 (the “Floating Rate Notes”), $1,300,000,000 aggregate principal amount of 5.334% Fixed-to-Floating Rate Senior Notes due 2030 (the “2030 Notes”) and $1,400,000,000 aggregate principal amount of 5.732% Fixed-to-Floating Rate Senior Notes due 2034 (the “2034 Notes” and…

    On GestorLens

    • 24 concentrated managers (+1 this quarter)
    • 1,583 13F filers
    • 1 insider bought in 180 days ($1.8M)

    Well-known investors: Markel Group, Giverny Capital, Viking Global

    GestorLens profile
  • Boot Barn Holdings

    BOOT
    • 16:47 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      James M Watkins (CFO & SECRETARY) bought 2,000 shares for $270,740 (avg. $135.37).

    On GestorLens

    • 4 concentrated managers (-1 this quarter)
    • 250 13F filers
    GestorLens profile
  • TransUnion

    TRU
    • 16:44 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      Dodge & Cox updated its stake: 13.5% (25,816,422 shares) (passive, 13G) as of September 30, 2026.

      Filed by: DODGE & COX

    On GestorLens

    • 4 concentrated managers (-1 this quarter)
    • 301 13F filers
    GestorLens profile
  • Aramark

    ARMK
    • 16:42 ETLeadership changesSEC 8-K/A 5.02

      Departure or appointment of directors or officers

      From the filing
      Aramark (the “Company”) previously filed a Current Report on Form 8-K (the “Original Filing”) to report that on August 4, 2026 the Board of Directors of the Company (the “Board”) elected Antony F. Spring as a director effective on that date.

    On GestorLens

    • 3 concentrated managers (+1 this quarter)
    • 315 13F filers
    GestorLens profile
  • TE Connectivity

    TEL
    • 16:41 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      Dodge & Cox updated its stake: 6.3% (18,212,906 shares) (passive, 13G) as of September 30, 2026.

      Filed by: DODGE & COX

    On GestorLens

    • 4 concentrated managers
    • 835 13F filers
    GestorLens profile
  • Sun Communities

    SUI
    • 16:40 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      Dodge & Cox reports no remaining shares as of September 30, 2026.

      Filed by: DODGE & COX

    On GestorLens

    • 4 concentrated managers
    • 289 13F filers
    GestorLens profile
  • Ecolab

    ECL
    • 16:40 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      David MacLennan (director) bought 600 shares for $184,875 (avg. $308.13).

    On GestorLens

    • 20 concentrated managers
    • 1,132 13F filers
    • 3 insiders bought in 180 days ($3.3M)

    Well-known investors: Markel Group, Gates Foundation Trust

    GestorLens profile
  • SBA Communications

    SBAC
    • 16:39 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      Dodge & Cox updated its stake: 12.1% (12,814,010 shares) (passive, 13G) as of September 30, 2026.

      Filed by: DODGE & COX

    On GestorLens

    • 3 concentrated managers (+1 this quarter)
    • 383 13F filers
    GestorLens profile
  • MetLife

    MET
    • 16:36 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      Dodge & Cox updated its stake: 5.3% (33,642,167 shares) (passive, 13G) as of September 30, 2026.

      Filed by: DODGE & COX

    On GestorLens

    • 1 concentrated managers
    • 1,005 13F filers
    • 1 13D filings in the last year
    GestorLens profile
  • Advanced Drainage Systems

    WMS
    • 16:36 ETOtherSEC 8-K 7.01

      Regulation FD disclosure

      Company headline: “ADVANCED DRAINAGE SYSTEMS CLOSES ACQUISITION OF STORMTRAP INVESTMENTS LLC FROM PSP CAPITAL”

      From the company's release
      Advanced Drainage Systems, Inc. (NYSE: WMS) (“ADS” or the “Company”), a leading provider of innovative water management solutions in the stormwater and onsite wastewater industries today announced that it has completed the previously disclosed acquisition of StormTrap Investments LLC (“StormTrap”), an industry leader in large volume, space-constrained, highly engineered stormwater solutions.

    On GestorLens

    • 2 concentrated managers
    • 324 13F filers
    GestorLens profile
  • Target

    TGT
    • 16:35 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      Sally Grimes joins the board, effective December 1, 2026.

      Company headline: “Target Appoints Sally Grimes to Board of Directors”

      From the filing
      On November 11, 2026, the Board of Directors of Target Corporation (“Target”) elected Sally Grimes as a director of Target, effective as of December 1, 2026.

    On GestorLens

    • 5 concentrated managers
    • 1,347 13F filers
    GestorLens profile
  • Gemini Space Station

    GEMI
    • 16:35 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q3 2026 results: revenue of $40.9 million.

      Company headline: “Gemini Reports Third Quarter 2026 Results”

      Also: Regulation FD disclosure

      From the company's release
      Total revenue of $40.9 million, with services revenue and interest income at 59% of net revenue as platform spot trading volume declined 73% year-over-year

    On GestorLens

    • 51 13F filers
    • 1 13D filings in the last year

    Well-known investors: Tiger Global

    GestorLens profile
  • Incyte

    INCY
    • 16:35 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      Dodge & Cox reports 5% (10,064,186 shares), 5% or less as of September 30, 2026.

      Filed by: DODGE & COX

    On GestorLens

    • 1 concentrated managers
    • 556 13F filers
    • 1 13D filings in the last year
    GestorLens profile
  • FedEx Freight Holding

    FDXF
    • 16:33 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      Dodge & Cox reported a stake: 5.4% (8,041,090 shares) (passive, 13G) as of September 30, 2026.

      Filed by: DODGE & COX

    On GestorLens

    • 6 concentrated managers (-2 this quarter)
    • 704 13F filers

    Well-known investors: Viking Global, Gates Foundation Trust

    GestorLens profile
  • Venture Global

    VG
    • 16:33 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Fory L Musser Iv (officer) may sell up to 500,000 shares (~$6.6 million, 0.09% of shares outstanding) on or about November 12, 2026.

    On GestorLens

    • 4 concentrated managers (+1 this quarter)
    • 189 13F filers
    • 1 insider bought in 180 days ($15,987)
    GestorLens profile
  • Elanco Animal Health

    ELAN
    • 16:32 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      Dodge & Cox updated its stake: 12.3% (61,430,997 shares) (passive, 13G) as of September 30, 2026.

      Filed by: DODGE & COX

    On GestorLens

    • 1 concentrated managers
    • 306 13F filers
    • 7 insiders bought in 180 days ($1.7M)
    GestorLens profile
  • Olema Pharmaceuticals

    OLMA
    • 16:30 ETOtherSEC 8-K 8.01

      Other events

      Company headline: “Olema Oncology Announces Corporate Name Change”

      Also: Amendments to bylaws or fiscal year; Regulation FD disclosure

      From the company's release
      Olema Oncology, Inc. (formerly Olema Pharmaceuticals, Inc.) (“Olema” or “Olema Oncology”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer and beyond, announced that, effective today, it has changed its corporate name from “Olema Pharmaceuticals, Inc.” to “Olema Oncology…

    On GestorLens

    • 73 13F filers
    • 1 13D filings in the last year

    Well-known investors: Stanley Druckenmiller

    GestorLens profile
  • Applied Digital

    APLD
    • 16:30 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      Jane Street Group and 5 related filers updated their stake: 6.3% (19,835,217 shares) (passive, 13G) as of September 30, 2025.

      Filed by: JANE STREET GROUP, LLC

    On GestorLens

    • 287 13F filers
    • 2 insiders bought in 180 days ($6.7M)
    • 1 13D filings in the last year

    Well-known investors: Tiger Global, Dan Loeb

    GestorLens profile
  • Meta Platforms

    META
    • 16:27 ETOtherSEC 8-K 8.01

      Other events

      From the filing
      On November 12, 2026, Meta Platforms, Inc. (the “Company”) completed an offering of €1,750,000,000 aggregate principal amount of its 4.300% Senior Notes due 2031 (the “2031 Notes”), €1,250,000,000 aggregate principal amount of its 4.650% Senior Notes due 2033 (the “2033 Notes”), €1,000,000,000 aggregate principal amount of its 4.900% Senior Notes due 2035 (the “2035 Notes”)…

    On GestorLens

    • 91 concentrated managers (+5 this quarter)
    • 3,613 13F filers

    Well-known investors: Markel Group, Bill Ackman, ValueAct, Tiger Global and 4 more

    GestorLens profile
  • General Electric

    GE
    • 16:25 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: H Lawrence Culp Jr may sell up to 8,000 shares (~$2.7 million) on or about November 11, 2026.

    On GestorLens

    • 24 concentrated managers (-2 this quarter)
    • 2,277 13F filers

    Well-known investors: Nelson Peltz, Chris Hohn, Semper Augustus

    GestorLens profile
  • Alphabet

    GOOGL3 filings
    • 16:25 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: The Lawrence Page Trust III (affiliate) may sell up to 34,040 shares (~$9.9 million) on or about November 12, 2026.

    • 16:23 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: The Lawrence Page Trust II (affiliate) may sell up to 19,520 shares (~$5.7 million) on or about November 12, 2026.

    • 16:22 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: The Lawrence Page Trust (affiliate) may sell up to 454,120 shares (~$132.6 million) on or about November 12, 2026.

    On GestorLens

    • 124 concentrated managers (+5 this quarter)
    • 4,067 13F filers

    Well-known investors: Markel Group, Li Lu, Berkshire Hathaway, Tiger Global and 4 more

    GestorLens profile
  • Tapestry

    TPR2 filings
    • 16:24 ETLeadership changesSEC 8-K/A 5.02

      Departure or appointment of directors or officers

      Vote results of the annual shareholder meeting held on November 11, 2026.

      Also: Shareholder vote results

      From the filing
      On November 11, 2026, the Company held its Annual Meeting of Stockholders (the "Annual Meeting").
    • 06:56 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Joanne C. Crevoiserat (officer, director) may sell up to 66,063 shares (~$8.8 million) on or about November 11, 2026.

    On GestorLens

    • 1 concentrated managers
    • 629 13F filers
    GestorLens profile
  • Emerson Electric

    EMR
    • 16:23 ETOtherSEC 8-K 8.01

      Other events

      From the filing
      On November 10, 2026, Emerson Electric Co. (the “Company”) entered into a pricing agreement (the “Pricing Agreement”) dated November 10, 2026 (incorporating the Underwriting Agreement Standard Provisions dated November 10, 2026 (the “Standard Provisions”)) with J.P.

    On GestorLens

    • 21 concentrated managers (-1 this quarter)
    • 1,665 13F filers
    GestorLens profile
  • Glaukos

    GKOS
    • 16:23 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Joseph E Gilliam (officer) may sell up to 44,917 shares (~$11.1 million, 0.08% of shares outstanding) on or about November 12, 2026.

    On GestorLens

    • 3 concentrated managers (+1 this quarter)
    • 226 13F filers
    GestorLens profile
  • Live Nation Entertainment

    LYV
    • 16:22 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Michael James Rapino (officer, director) may sell up to 195,578 shares (~$35.4 million, 0.08% of shares outstanding) on or about November 12, 2026.

    On GestorLens

    • 3 concentrated managers
    • 492 13F filers
    • 2 13D filings in the last year

    Well-known investors: Dan Loeb, ValueAct

    GestorLens profile
  • First Solar

    FSLR
    • 16:22 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      Jane Street Group and 3 related filers updated their stake: 6.8% (7,264,895 shares) (passive, 13G) as of September 30, 2026.

      Filed by: JANE STREET GROUP, LLC

    On GestorLens

    • 8 concentrated managers (+1 this quarter)
    • 597 13F filers

    Well-known investors: Soros Fund

    GestorLens profile
  • Gilead Sciences

    GILD
    • 16:21 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Kelly Kramer (director) may sell up to 10,376 shares (~$1.8 million) on or about November 12, 2026.

    On GestorLens

    • 12 concentrated managers
    • 1,607 13F filers
    GestorLens profile
  • York Space Systems

    YSS2 filings
    • 16:20 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q3 2026 results: revenue of $84.2 million.

      Company headline: “York Space Systems Reports Third Quarter 2026 Results”

      From the company's release
      Revenue for the quarter was $84.2 million, down $6.6 million, or 7% year over year.
    • 16:18 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      From the filing
      In connection with Mr. Frantz’s appointment as permanent Chief Financial Officer, the Board approved the following changes to Mr. Frantz’s compensation, effective as of November 12, 2026: (i) an annual base salary of $400,000, (ii) a target annual incentive bonus opportunity equal to 75% of his annual base salary, and (iii) eligibility to participate in the Company’s long-term incentive program…

    On GestorLens

    • 71 13F filers

    Well-known investors: Soros Fund

    GestorLens profile
  • Oruka Therapeutics

    ORKA2 filings
    • 16:20 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Arjun Agarwal (officer) may sell up to 29,458 shares (~$3.2 million) on or about November 12, 2026.

    • 16:19 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Kristine Ball (director) may sell up to 18,000 shares (~$1.9 million) on or about November 12, 2026.

    On GestorLens

    • 105 13F filers
    • 2 13D filings in the last year

    Well-known investors: Viking Global

    GestorLens profile
  • Exlservice Holdings

    EXLS
    • 16:20 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Rohit Kapoor may sell up to 100,000 shares (~$4.3 million, 0.07% of shares outstanding) on or about November 12, 2026.

    On GestorLens

    • 3 concentrated managers (+1 this quarter)
    • 255 13F filers
    GestorLens profile
  • Torm

    TRMD
    • 16:18 ETOtherSEC 6-K

      Foreign issuer report

      Company announcement.

      Company headline: “TORM plc capital increase in connection with exercise of Restricted Share Units as part of TORM’s incentive program”

      From the company's release
      TORM plc capital increase in connection with exercise of Restricted Share Units as part of TORM’s incentive program TORM plc (Nasdaq: TRMD or TRMD A) has increased its share capital by 48,167 Class A shares, corresponding to a nominal increase of USD 481.67, as a result of the exercise of a corresponding number of Restricted Share Units (“RSUs”).

    On GestorLens

    • 66 13F filers
    • 3 13D filings in the last year

    Well-known investors: Howard Marks

    GestorLens profile
  • Merck

    MRK
    • 16:17 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Richard Robert Deluca JR (officer) may sell up to 58,185 shares (~$8.6 million) on or about November 12, 2026.

    On GestorLens

    • 45 concentrated managers (+1 this quarter)
    • 2,809 13F filers

    Well-known investors: Semper Augustus

    GestorLens profile
  • Oklo

    OKLO
    • 16:17 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      Jane Street Group and 2 related filers reported a stake: 5.1% (9,533,787 shares) (passive, 13G) as of September 30, 2026.

      Filed by: JANE STREET GROUP, LLC

    On GestorLens

    • 2 concentrated managers (-1 this quarter)
    • 362 13F filers
    • 1 13D filings in the last year
    GestorLens profile
  • Sempra

    SRE
    • 16:16 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      Also: Other events

      From the filing
      On July 9, 2026, Sempra reported that its Board of Directors had appointed Justin C. Bird as Executive Vice President and Chief Financial Officer of Sempra, with such appointment to be effective on or around the completion of the sale described above in Item 8.01.

    On GestorLens

    • 5 concentrated managers
    • 776 13F filers

    Well-known investors: Soros Fund

    GestorLens profile
  • Fair Isaac

    FICO2 filings
    • 16:15 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: William J. Lansing may sell up to 10,933 shares (~$8.0 million, 0.05% of shares outstanding) on or about November 12, 2026.

    • 07:59 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: William J Lansing (director, officer) may sell up to 9,782 shares (~$7.1 million, 0.05% of shares outstanding) on or about November 11, 2026.

    On GestorLens

    • 8 concentrated managers (-3 this quarter)
    • 419 13F filers
    • 1 insider bought in 180 days ($20,461)

    Well-known investors: Akre Capital, Terry Smith

    GestorLens profile
  • QXO

    QXO2 filings
    • 16:15 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q3 2026 results: revenue of $4.9 billion; loss per share of $0.17.

      Company headline: “QXO Reports Third Quarter 2026 Results”

      From the company's release
      Net sales totaled $4.90 billion for the three months ended September 30, 2026, including $1.64 billion from TopBuild and $589 million from Kodiak.
    • 06:06 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      Company headline: “QXO Appoints Dev Ahuja as Chief Financial Officer and Promotes Ihsan Essaid to Vice Chairman”

      Also: Regulation FD disclosure

      From the filing
      On November 12, 2026, QXO, Inc. (the “Company”) announced the appointment of Dev Ahuja as the Company’s Chief Financial Officer, effective as of his anticipated start date in January 2027.

    On GestorLens

    • 7 concentrated managers (+1 this quarter)
    • 443 13F filers
    • 1 13D filings in the last year

    Well-known investors: Soros Fund

    GestorLens profile
  • Weyerhaeuser

    WY
    • 16:15 ETOtherSEC 8-K 7.01

      Regulation FD disclosure

      Company headline: “INDUSTRY-LEADING PERFORMANCE Significant, Sustainable Margin Improvement Accelerated By Innovation Operational Excellence Relative Competitive Performance Innovation 36”

      From the company's release
      We Remove Nearly Four Times More Carbon Dioxide Than We Emit Our carbon record 31 million mtCO2e in 2025 We Set An Ambitious, Science-Based Target To Reduce Emissions By 2030 10 million mtCO2e in 2025 Scope 1 & 2 Scope 3 We are on the pathway to net-zero emissions The world needs more carbon removals The world needs less carbon emissions 42% 25% TRACK 1 Carbon Emissions TRACK 2 Carbon Removals 2.3-3.7 billion mtCO2e…

    On GestorLens

    • 5 concentrated managers
    • 525 13F filers

    Well-known investors: Markel Group

    GestorLens profile
  • Eastman Chemical

    EMN
    • 16:13 ETDeals and acquisitionsSEC 8-K 1.01

      Entry into a material agreement

      Also: Other events

      From the filing
      On November 12, 2026, Eastman Chemical Company (the “Company”) issued $300,000,000 aggregate principal amount of 5.500% Notes due 2030 (the “Notes”) in a public offering (the “Notes Offering”) pursuant to a registration statement on Form S-3 (File No. 333-280083) and a preliminary prospectus supplement and prospectus supplement related to the offering of the Notes, each as previously filed with the SEC.

    On GestorLens

    • 1 concentrated managers
    • 408 13F filers
    • 1 insider bought in 180 days ($159,989)

    Well-known investors: Markel Group

    GestorLens profile
  • UBER Technologies

    UBER
    • 16:11 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Derek Anthony West (officer) may sell up to 35,800 shares (~$2.5 million) on or about November 12, 2026.

    On GestorLens

    • 26 concentrated managers (-3 this quarter)
    • 1,498 13F filers
    • 2 insiders bought in 180 days ($15.3M)

    Well-known investors: Markel Group, Bill Ackman, David Tepper, Terry Smith and 2 more

    GestorLens profile
  • ON Semiconductor

    ON
    • 16:10 ETDeals and acquisitionsSEC 8-K 1.01

      Entry into a material agreement

      Also: New direct financial obligation

      From the filing
      The proceeds of any borrowings under the Revolving Credit Facility will be available for working capital needs and other general corporate purposes of the Company and its restricted subsidiaries, including the financing of permitted acquisitions and any other purposes not prohibited by the A&R Credit Agreement.

    On GestorLens

    • 2 concentrated managers
    • 558 13F filers

    Well-known investors: Soros Fund

    GestorLens profile
  • TPG

    TPG
    • 16:10 ET5%+ stakesSEC Schedule 13D/A

      Change in a 5%+ stake with activist intent

      Coulter James G. and 2 related filers updated their stake: 54.6% (206,714,316 shares) (active, 13D) as of November 9, 2026.

      Filed by: TPG GP A, LLC

      From the filing
      This Amendment amends and supplements Item 4 of the Original Schedule 13D by inserting the following before the penultimate paragraph: "Q4 2026 Exchange Pursuant to the Exchange Agreement, on November 9, 2026, 6,545,340 Common Units were ultimately distributed to certain partners of TPG Partner Holdings…

    On GestorLens

    • 3 concentrated managers
    • 196 13F filers
    • 1 13D filings in the last year

    Well-known investors: Soros Fund

    GestorLens profile
  • Nebius Group

    NBIS2 filings
    • 16:10 ETOtherSEC 6-K

      Foreign issuer report

      Company announcement.

      Company headline: “Operating and Financial Review and Prospects”

      From the company's release
      Nebius, a global AI cloud platform, the core business of Nebius Group N.V., the parent company (the “Company”), together with its consolidated subsidiaries (collectively “Nebius Group” or the “Group”), delivers a unified full-stack AI cloud that spans the complete AI journey – from compute capacity to software and services – that enables fast and efficient training and inference at scale.
    • 09:22 ETEarningsSEC 6-K

      Foreign issuer report

      Company headline: “Third quarter 2026 financial results”

    On GestorLens

    • 5 concentrated managers (+1 this quarter)
    • 638 13F filers
    • 1 insider bought in 180 days ($330,440)

    Well-known investors: Lone Pine, Soros Fund

    GestorLens profile
  • US Foods Holding

    USFD
    • 16:09 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      Lisa M. Lambert joins the board.

      Company headline: “Mike Neese Sara Matheu”

      Also: Regulation FD disclosure

      From the filing
      On November 12, 2026, the Board of Directors (the “Board”) of US Foods Holding Corp. (the “Company”) increased the size of the Board to nine directors and appointed Lisa M. Lambert to the Board, effective immediately.

    On GestorLens

    • 2 concentrated managers
    • 378 13F filers

    Well-known investors: Lone Pine, Viking Global

    GestorLens profile
  • Steris

    STE2 filings
    • 16:08 ETOtherSEC 8-K 8.01

      Other events

      From the filing
      The Company intends to use the net proceeds from the Offering, together with borrowings under the delayed draw term loan agreement, dated November 4, 2026, among the Issuer and the Guarantors, the lenders party thereto and J.P.
    • 10:20 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Karen L Burton (officer) may sell up to 5,880 shares (~$1.5 million) on or about November 11, 2026.

    On GestorLens

    • 6 concentrated managers
    • 497 13F filers
    GestorLens profile
  • Coca-Cola

    KO
    • 16:08 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Nancy Quan (officer) may sell up to 15,000 shares (~$1.5 million) on or about November 12, 2026.

    On GestorLens

    • 46 concentrated managers (+2 this quarter)
    • 2,643 13F filers

    Well-known investors: Berkshire Hathaway, Soros Fund, Semper Augustus

    GestorLens profile
  • Icon

    ICLR
    • 16:07 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Ciaran Murray (director) may sell up to 10,000 shares (~$2.0 million) on or about November 12, 2026.

    On GestorLens

    • 5 concentrated managers (-1 this quarter)
    • 218 13F filers
    GestorLens profile
  • Liftoff Mobile

    LFTO
    • 16:07 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q3 2026 results.

      Company headline: “Liftoff Mobile Announces Third Quarter 2026 Financial Results”

      From the company's release
      Core Advertising Revenue2 was $237 million in the third quarter, an increase of 33% year-over-year and 8% quarter-over-quarter.

    On GestorLens

    • 31 13F filers
    • 1 13D filings in the last year

    Well-known investors: Soros Fund

    GestorLens profile
  • Cisco Systems

    CSCO
    • 16:06 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Company headline: “CISCO REPORTS FIRST QUARTER EARNINGS”

      From the company's release
      Cisco (NASDAQ: CSCO) today reported first quarter results for the period ended October 24, 2026. Cisco reported first quarter revenue of $18.5 billion, net income on a generally accepted accounting principles (GAAP) basis of $4.6 billion or $1.14 per share, and non-GAAP net income of $5.6 billion or $1.40 per share.

    On GestorLens

    • 42 concentrated managers (-1 this quarter)
    • 2,890 13F filers

    Well-known investors: Markel Group

    GestorLens profile
  • Hyatt Hotels

    H
    • 16:06 ETDeals and acquisitionsSEC 8-K 1.01

      Entry into a material agreement

      Also: Other events

      From the filing
      On November 12, 2026, Hyatt Hotels Corporation (the “Company”) issued and sold $400,000,000 of its 5.950% Senior Notes due 2033 (the “Notes”) in a public offering (the “Offering”) pursuant to an effective Registration Statement on Form S-3 (Registration No. 333-298633) (the “Registration Statement”).

    On GestorLens

    • 3 concentrated managers (-1 this quarter)
    • 266 13F filers
    • 3 13D filings in the last year
    GestorLens profile
  • Marriott International

    MAR
    • 16:06 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Benjamin T. Breland (officer) may sell up to 2,408 shares (~$1.0 million) on or about November 12, 2026.

    On GestorLens

    • 9 concentrated managers (+3 this quarter)
    • 1,163 13F filers
    • 1 13D filings in the last year

    Well-known investors: Markel Group, Terry Smith

    GestorLens profile
  • Zimmer Biomet Holdings

    ZBH
    • 16:05 ETDeals and acquisitionsSEC 8-K 1.01

      Entry into a material agreement

      Also: New direct financial obligation

      From the filing
      On November 5, 2026, Zimmer Biomet Holdings, Inc. (the “Company”) entered into an underwriting agreement (the “EUR Underwriting Agreement”) with Barclays Bank PLC, Citigroup Global Markets Limited, HSBC Bank plc, Morgan Stanley & Co. International plc and RBC Europe Limited, as representatives of the underwriters named therein (collectively, the “EUR Underwriters”)…

    On GestorLens

    • 3 concentrated managers
    • 580 13F filers
    GestorLens profile
  • Applied Optoelectronics

    AAOI
    • 16:05 ETDeals and acquisitionsSEC 8-K 1.01

      Entry into a material agreement

      Also: Termination of a material agreement

      From the filing
      On November 6, 2026, Applied Optoelectronics, Inc. (the “Company”) entered into a Purchase and Sale Agreement (the “Purchase Agreement”) with Hightower Phase I Owner, LLC, a Delaware limited liability company (“Seller”), for the acquisition of Buildings 1, 2 and 3 at Hightower Business Park – Phase I in Houston, Texas, together with the related land…

    On GestorLens

    • 4 concentrated managers (+2 this quarter)
    • 247 13F filers
    GestorLens profile
  • The Toro

    TTC
    • 16:05 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      Kayne Anderson Rudnick Investment Management updated its stake: 7.1% (6,766,450 shares) (passive, 13G) as of September 30, 2026.

      Filed by: KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC

    On GestorLens

    • 2 concentrated managers (+1 this quarter)
    • 368 13F filers
    • 1 insider bought in 180 days ($14,402)
    GestorLens profile
  • Andersen Group

    ANDG2 filings
    • 16:05 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      Kayne Anderson Rudnick Investment Management updated its stake: 7.8% (1,437,675 shares) (passive, 13G) as of September 30, 2026.

      Filed by: KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC

    • 16:02 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q3 2026 (ended September 30, 2026) results.

      Company headline: “Andersen Group Reports Third Quarter Revenue Growth of 18.7% to $337.3 Million Revenue Growth Reflects Continued Strength Across Service Lines and Geographic Markets”

      Also: Regulation FD disclosure

      From the company's release
      Andersen Group Inc. (NYSE: ANDG) ("Andersen" or the "Company") today reported strong financial results for the third quarter ended September 30, 2026, with revenue increasing 18.7% to $337.3 million, driven by continued double-digit growth and an expanding contribution from acquisitions.

    On GestorLens

    • 1 concentrated managers
    • 43 13F filers
    • 1 insider bought in 180 days ($84,786)

    Well-known investors: Soros Fund

    GestorLens profile
  • Bright Horizons Family Solutions

    BFAM
    • 16:05 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      Kayne Anderson Rudnick Investment Management reports a 4.3% stake (2,110,643 shares), below 5% as of September 30, 2026.

      Filed by: KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC

    On GestorLens

    • 217 13F filers

    Well-known investors: Giverny Capital

    GestorLens profile
  • Goosehead Insurance

    GSHD
    • 16:05 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      Kayne Anderson Rudnick Investment Management updated its stake: 7.6% (1,799,999 shares) (passive, 13G) as of September 30, 2026.

      Filed by: KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC

    On GestorLens

    • 129 13F filers
    • 3 insiders bought in 180 days ($19M)
    • 1 13D filings in the last year

    Well-known investors: Akre Capital

    GestorLens profile
  • Hawkins

    HWKN
    • 16:05 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      Kayne Anderson Rudnick Investment Management updated its stake: 9.1% (1,896,410 shares) (passive, 13G) as of September 30, 2026.

      Filed by: KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC

    On GestorLens

    • 1 concentrated managers
    • 163 13F filers
    • 2 insiders bought in 180 days ($261,572)

    Well-known investors: Giverny Capital

    GestorLens profile
  • Installed Building Products

    IBP2 filings
    • 16:05 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      Kayne Anderson Rudnick Investment Management updated its stake: 7.8% (2,082,910 shares) (passive, 13G) as of September 30, 2026.

      Filed by: KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC

    • 07:31 ETDeals and acquisitionsSEC 8-K 1.01

      Entry into a material agreement

      Also: Unregistered sale of equity; Regulation FD disclosure

      From the filing
      On November 12, 2026 (the “Closing Date”), Installed Building Products, Inc., a Delaware corporation (the “Company”), entered into and consummated the transactions contemplated by an Agreement and Plan of Merger (the “Merger Agreement”) by and among the Company, Platform MSI, Inc., a Delaware corporation (“Merger Sub I”), and IBP Mechanical & Industrial Installation, LLC…

    On GestorLens

    • 239 13F filers
    • 1 insider bought in 180 days ($198,610)

    Well-known investors: Giverny Capital

    GestorLens profile
  • THOR Industries

    THO2 filings
    • 16:05 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      Kayne Anderson Rudnick Investment Management updated its stake: 5.2% (2,690,130 shares) (passive, 13G) as of September 30, 2026.

      Filed by: KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC

    • 10:38 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      Life Cycle Investment Partners reported a stake: 8.1% (4,191,077 shares) (passive, 13G) as of September 30, 2026.

      Filed by: Life Cycle Investment Partners Ltd

    On GestorLens

    • 4 concentrated managers
    • 229 13F filers
    GestorLens profile
  • UFP Industries

    UFPI
    • 16:05 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      Kayne Anderson Rudnick Investment Management updated its stake: 5.2% (2,843,888 shares) (passive, 13G) as of September 30, 2026.

      Filed by: KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC

    On GestorLens

    • 209 13F filers

    Well-known investors: Markel Group

    GestorLens profile
  • UL Solutions

    ULS
    • 16:05 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      Kayne Anderson Rudnick Investment Management reports a 4.7% stake (3,639,432 shares), below 5% as of September 30, 2026.

      Filed by: KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC

    On GestorLens

    • 201 13F filers

    Well-known investors: Soros Fund

    GestorLens profile
  • Alnylam Pharmaceuticals

    ALNY2 filings
    • 16:05 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      Charles Elliott Sigal (director) bought 1,600 shares for $243,600 (avg. $152.25).

    • 16:01 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      Amy W Schulman (director) bought 1,910 shares for $299,526 (avg. $156.82).

    On GestorLens

    • 4 concentrated managers (+1 this quarter)
    • 415 13F filers
    GestorLens profile
  • GoPro

    GPRO
    • 16:05 ETDeals and acquisitionsSEC 8-K 1.01

      Entry into a material agreement

      From the filing
      On November 6, 2026, GoPro, Inc., a Delaware corporation (the “Company”), entered into Amendment No. 1 (the “Amendment”) to the Agreement and Plan of Merger, dated as of September 1, 2026 (as amended, the “Merger Agreement”), by and among Action Acquisition LLC, a Delaware limited liability company (“Parent”), Starman Optical, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent (“Merger Sub”)…

    On GestorLens

    • 77 13F filers
    • 1 13D filings in the last year

    Well-known investors: David Einhorn

    GestorLens profile
  • HawkEye 360

    HAWK
    • 16:04 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q3 2026 results: revenue of $59.3 million.

      Company headline: “HawkEye 360 Announces Third Quarter 2026 Financial Results”

      From the company's release
      Revenue of $59.3 million, up 84% compared to the prior-year period of $32.2 million.

    On GestorLens

    • 45 13F filers

    Well-known investors: Soros Fund

    GestorLens profile
  • Cerebras Systems

    CBRS2 filings
    • 16:03 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q3 2026 (ended September 30, 2026) results.

      Company headline: “Cerebras Systems Delivers Record Revenue in Third Quarter 2026, Raises Full-Year Outlook”

      From the company's release
      Strong liquidity with cash, cash equivalents, restricted cash, and short-term investments of $7.8 billion and debt capacity of $850 million.
    • 08:06 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      Foundation Capital Management Co. VIII and 4 related filers updated their stake: 7.6% (9,521,326 shares) (passive, 13G) as of September 30, 2026.

      Filed by: Foundation Capital Management Co. VIII, L.L.C.

    On GestorLens

    • 3 concentrated managers (+1 this quarter)
    • 281 13F filers
    • 1 13D filings in the last year

    Well-known investors: Coatue, Dragoneer, Tiger Global, Soros Fund

    GestorLens profile
  • Linde

    LIN
    • 16:03 ETOtherSEC 8-K 8.01

      Other events

      From the filing
      The net proceeds of the offering were approximately €1,295 million, after giving effect to the fees to the Managers but before other fees and expenses of the offering.

    On GestorLens

    • 29 concentrated managers (-1 this quarter)
    • 1,568 13F filers
    • 1 insider bought in 180 days ($47,912)

    Well-known investors: Markel Group, Lone Pine, Soros Fund, Stanley Druckenmiller

    GestorLens profile
  • Applied Materials

    AMAT
    • 16:02 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Fiscal Q4 (ended October 25, 2026) results.

      Company headline: “APPLIED MATERIALS ANNOUNCES FOURTH QUARTER AND FISCAL YEAR 2026 RESULTS”

      From the company's release
      Applied generated record revenue of $10.41 billion. On a GAAP basis, the company reported gross margin of 50.4 percent, record operating income of $3.66 billion or 35.1 percent of revenue, and earnings per share (EPS) of $3.40.

    On GestorLens

    • 30 concentrated managers (-4 this quarter)
    • 2,270 13F filers

    Well-known investors: Markel Group, Coatue, Lone Pine, Tiger Global

    GestorLens profile
  • Arrowhead Pharmaceuticals

    ARWR
    • 16:01 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Company headline: “Arrowhead Pharmaceuticals Reports 2026 Fiscal Year-End Results”

      From the company's release
      Deep, durable, and consistent median triglyceride (TG) reductions of 79% and 81% from baseline were observed in SHASTA-3 and SHASTA-4, respectively.

    On GestorLens

    • 3 concentrated managers
    • 257 13F filers
    GestorLens profile
  • TEVA Pharmaceutical Industries

    TEVA
    • 16:00 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Mark Sabag may sell up to 44,710 shares (~$2.0 million) on or about November 12, 2026.

    On GestorLens

    • 2 concentrated managers (+1 this quarter)
    • 320 13F filers
    GestorLens profile
  • Stitch FIX

    SFIX
    • 15:41 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      Renaissance Technologies and 1 related filer report a 4.47% stake (5,300,458 shares), below 5% as of September 30, 2026.

      Filed by: RENAISSANCE TECHNOLOGIES LLC

    On GestorLens

    • 85 13F filers

    Well-known investors: Coatue

    GestorLens profile
  • NN

    NNBR
    • 14:12 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      First Manhattan and 2 related filers report a 3.3% stake (2,742,000 shares), below 5% as of September 30, 2026.

      Filed by: FIRST MANHATTAN CO. LLC.

    On GestorLens

    • 1 concentrated managers
    • 48 13F filers
    • 2 13D filings in the last year

    Well-known investors: Howard Marks

    GestorLens profile
  • Church & Dwight

    CHD
    • 13:28 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Janet Vergis (director) may sell up to 11,590 shares (~$1.3 million) on or about November 11, 2026.

    On GestorLens

    • 7 concentrated managers
    • 672 13F filers

    Well-known investors: Terry Smith

    GestorLens profile
  • Enterprise Products Partners

    EPD
    • 13:13 ETDeals and acquisitionsSEC 8-K 1.01

      Entry into a material agreement

      Company headline: “DESCRIPTION OF THE NOTES”

      Also: Other events

      From the filing
      On November 12, 2026, Enterprise Products Partners L.P. (the “Partnership”), Enterprise Products OLPGP, Inc. (“EPOGP”) and Enterprise Products Operating LLC (“EPO”) completed the public offering of (i) $750 million principal amount of EPO’s 5.20% senior notes due 2032 (the “Senior Notes OOO”) and (ii) $750 million principal amount of EPO’s 5.65% senior notes due 2037 (the “Senior Notes PPP” and…

    On GestorLens

    • 16 concentrated managers (-2 this quarter)
    • 1,132 13F filers
    • 1 13D filings in the last year

    Well-known investors: Markel Group, Bruce Berkowitz

    GestorLens profile
  • Costco Wholesale

    COST
    • 13:06 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: James C Klauer may sell up to 2,500 shares (~$2.7 million) on or about November 12, 2026.

    On GestorLens

    • 52 concentrated managers (-2 this quarter)
    • 3,025 13F filers

    Well-known investors: Markel Group, Semper Augustus

    GestorLens profile
  • Liberty Media

    FWONK
    • 12:52 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Charles Carey (director) may sell up to 274,331 shares (~$28.5 million, 0.12% of shares outstanding) on or about November 11, 2026.

    On GestorLens

    • 3 concentrated managers (+1 this quarter)
    • 342 13F filers
    • 1 13D filings in the last year

    Well-known investors: Tiger Global

    GestorLens profile
  • Texas Instruments

    TXN
    • 12:52 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Jean Hobby (director) may sell up to 8,758 shares (~$2.7 million) on or about November 12, 2026.

    On GestorLens

    • 24 concentrated managers (-2 this quarter)
    • 1,957 13F filers

    Well-known investors: Markel Group, Terry Smith, Soros Fund

    GestorLens profile
  • Delta Air Lines

    DAL
    • 12:13 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Steven M Sear (officer) may sell up to 17,768 shares (~$1.6 million) on or about November 12, 2026.

    On GestorLens

    • 3 concentrated managers (+1 this quarter)
    • 962 13F filers

    Well-known investors: Berkshire Hathaway, Stanley Druckenmiller

    GestorLens profile
  • NNN Reit

    NNN
    • 11:55 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      AQR Capital Management and 1 related filer report a 4.68% stake (8,979,113 shares), below 5% as of September 30, 2026.

      Filed by: AQR CAPITAL MANAGEMENT LLC

    On GestorLens

    • 2 concentrated managers
    • 358 13F filers
    GestorLens profile
  • nCino

    NCNO2 filings
    • 11:50 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      AQR Capital Management and 1 related filer report a 4.32% stake (4,572,543 shares), below 5% as of September 30, 2026.

      Filed by: AQR CAPITAL MANAGEMENT LLC

    • 07:43 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      Bank of Montreal and 8 related filers reported a stake: 5.31% (5,620,758 shares) (passive, 13G) as of September 30, 2026.

      Filed by: BANK OF MONTREAL /CAN/

    On GestorLens

    • 3 concentrated managers
    • 160 13F filers
    • 1 13D filings in the last year
    GestorLens profile
  • Marketaxess Holdings

    MKTX
    • 11:47 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      AQR Capital Management and 1 related filer report a 3.5% stake (1,231,052 shares), below 5% as of September 30, 2026.

      Filed by: AQR CAPITAL MANAGEMENT LLC

    On GestorLens

    • 3 concentrated managers (-1 this quarter)
    • 219 13F filers
    GestorLens profile
  • Liberty Global

    LBTYK
    • 11:43 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      AQR Capital Management and 1 related filer report a 4.28% stake (7,558,426 shares), below 5% as of September 30, 2026.

      Filed by: AQR CAPITAL MANAGEMENT LLC

    On GestorLens

    • 1 concentrated managers
    • 150 13F filers

    Well-known investors: Seth Klarman

    GestorLens profile
  • Expeditors International of Washington

    EXPD
    • 11:42 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Company headline: “Sterling Plaza 2, 3rd Floor”

      Also: Regulation FD disclosure

    On GestorLens

    • 4 concentrated managers (+1 this quarter)
    • 613 13F filers
    GestorLens profile
  • Huntsman

    HUN
    • 11:28 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      AQR Capital Management and 1 related filer report a 1.53% stake (2,682,901 shares), below 5% as of September 30, 2026.

      Filed by: AQR CAPITAL MANAGEMENT LLC

    On GestorLens

    • 1 concentrated managers
    • 166 13F filers
    • 1 insider bought in 180 days ($981,000)
    • 1 13D filings in the last year

    Well-known investors: Soros Fund

    GestorLens profile
  • Genpact

    G
    • 11:22 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      AQR Capital Management and 1 related filer report a 4.21% stake (7,069,299 shares), below 5% as of September 30, 2026.

      Filed by: AQR CAPITAL MANAGEMENT LLC

    On GestorLens

    • 6 concentrated managers (+1 this quarter)
    • 276 13F filers
    GestorLens profile
  • Franklin Templeton

    BEN
    • 11:21 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Matthew Nicholls (officer) may sell up to 160,000 shares (~$5.8 million) on or about November 11, 2026.

    On GestorLens

    • 1 concentrated managers
    • 428 13F filers
    GestorLens profile
  • Draftkings

    DKNG
    • 11:09 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      AQR Capital Management and 1 related filer report a 4.04% stake (20,064,943 shares), below 5% as of September 30, 2026.

      Filed by: AQR CAPITAL MANAGEMENT LLC

    On GestorLens

    • 1 concentrated managers
    • 352 13F filers
    • 1 insider bought in 180 days ($349,987)
    GestorLens profile
  • Amdocs

    DOX2 filings
    • 11:09 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      Yvette Kanouff (director) bought 2,400 shares for $100,800 (avg. $42.00).

    • 10:59 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      Amos Genish (director) bought 3,565 shares for $149,730 (avg. $42.00).

    On GestorLens

    • 4 concentrated managers (+1 this quarter)
    • 256 13F filers
    GestorLens profile
  • Axalta Coating Systems

    AXTA3 filings
    • 10:51 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      Barrow Hanley Mewhinney & Strauss reports a 4.7% stake (10,040,175 shares), below 5% as of September 30, 2026.

      Filed by: BARROW HANLEY MEWHINNEY & STRAUSS LLC

    • 08:00 ETMergers and tender offersSEC 425

      Communication about a merger or acquisition

      Axalta Coating Systems filed a communication about its merger.

      From the filing
      The following media release was issued by Axalta Coating Systems Ltd. in connection with the pending merger of equals transaction between Axalta Coating Systems Ltd. and Akzo Nobel N.V.:
    • 06:15 ETMergers and tender offersSEC 425

      Communication about a merger or acquisition

    On GestorLens

    • 197 13F filers

    Well-known investors: Seth Klarman

    GestorLens profile
  • Jackson Financial

    JXN
    • 10:49 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Laura Louene Prieskorn may sell up to 49,355 shares (~$6.9 million, 0.07% of shares outstanding) on or about November 12, 2026.

    On GestorLens

    • 301 13F filers
    GestorLens profile
  • Pinnacle West Capital

    PNW
    • 10:47 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      Barrow Hanley Mewhinney & Strauss reported a stake: 5.4% (6,497,352 shares) (passive, 13G) as of September 30, 2026.

      Filed by: BARROW HANLEY MEWHINNEY & STRAUSS LLC

    On GestorLens

    • 3 concentrated managers
    • 425 13F filers
    GestorLens profile
  • Aptiv

    APTV
    • 10:40 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      Barrow Hanley Mewhinney & Strauss reported a stake: 5.5% (11,335,752 shares) (passive, 13G) as of September 30, 2026.

      Filed by: BARROW HANLEY MEWHINNEY & STRAUSS LLC

    On GestorLens

    • 3 concentrated managers (+1 this quarter)
    • 365 13F filers
    • 4 insiders bought in 180 days ($8.3M)

    Well-known investors: Viking Global

    GestorLens profile
  • Aecom

    ACM
    • 10:31 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      Barrow Hanley Mewhinney & Strauss reported a stake: 6.1% (7,807,318 shares) (passive, 13G) as of September 30, 2026.

      Filed by: BARROW HANLEY MEWHINNEY & STRAUSS LLC

    On GestorLens

    • 3 concentrated managers (+1 this quarter)
    • 309 13F filers
    • 1 insider bought in 180 days ($298,341)
    GestorLens profile
  • Vertex Pharmaceuticals

    VRTX
    • 10:23 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Charles F Wagner Jr (officer) may sell up to 15,286 shares (~$8.4 million) on or about November 12, 2026.

    On GestorLens

    • 14 concentrated managers (+2 this quarter)
    • 1,160 13F filers
    GestorLens profile
  • EchoStar

    ECHO
    • 10:17 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Stephen J Bye may sell up to 10,652 shares (~$1.1 million) on or about November 12, 2026.

    On GestorLens

    • 3 concentrated managers
    • 320 13F filers
    • 1 insider bought in 180 days ($90,410)
    • 1 13D filings in the last year

    Well-known investors: Carl Icahn

    GestorLens profile
  • Hanover Insurance Group

    THG
    • 10:12 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: John C Roche (officer, director) may sell up to 14,422 shares (~$3.6 million) on or about November 12, 2026.

    On GestorLens

    • 317 13F filers

    Well-known investors: Markel Group

    GestorLens profile
  • Johnson & Johnson

    JNJ
    • 10:00 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Elizabeth Forminard (officer) may sell up to 13,072 shares (~$3.7 million) on or about November 12, 2026.

    On GestorLens

    • 80 concentrated managers (-1 this quarter)
    • 3,391 13F filers

    Well-known investors: Markel Group, Soros Fund, Semper Augustus

    GestorLens profile
  • SEI Investments

    SEIC
    • 09:34 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      Loomis, Sayles updated its stake: 6.5% (7,803,457 shares) (passive, 13G) as of September 30, 2026.

      Filed by: LOOMIS SAYLES & CO L P

    On GestorLens

    • 374 13F filers

    Well-known investors: Markel Group

    GestorLens profile
  • Packaging Corp of America

    PKG
    • 09:27 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Mark W Kowlzan may sell up to 9,378 shares (~$2.4 million) on or about November 12, 2026.

    On GestorLens

    • 3 concentrated managers
    • 585 13F filers
    GestorLens profile
  • Investors Title

    ITIC
    • 09:24 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      Parker, Jr. Elton C. (director) bought 500 shares for $133,000 (avg. $266.00).

    On GestorLens

    • 60 13F filers

    Well-known investors: Markel Group

    GestorLens profile
  • Teledyne Technologies

    TDY
    • 09:23 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Cynthia Y Belak may sell up to 4,528 shares (~$2.9 million) on or about November 12, 2026.

    On GestorLens

    • 6 concentrated managers
    • 512 13F filers
    GestorLens profile
  • Vishay Intertechnology

    VSH
    • 09:11 ETOtherSEC 8-K 8.01

      Other events

      From the filing
      On November 12, 2026, Vishay Intertechnology, Inc. ("Vishay"), through a wholly-owned subsidiary, entered into a binding term sheet with Kaynes Technology India Limited ("Kaynes Technology") to establish a semiconductor manufacturing joint venture in India.

    On GestorLens

    • 228 13F filers

    Well-known investors: Soros Fund

    GestorLens profile
  • Marvell Technology

    MRVL
    • 09:11 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      Company headline: “Marvell Appoints Three New Independent Directors to its Board”

      From the filing
      On November 11, 2026 the Board of Directors (the "Board") of Marvell Technology, Inc. (the "Company") approved an increase in the size of the Board from seven (7) to ten (10) members and the appointments of Donna C. Morris, Douglas R. Bettinger and Sasan K. Goodarzi to the Board, in each case effective November 12, 2026.

    On GestorLens

    • 16 concentrated managers (+2 this quarter)
    • 1,497 13F filers

    Well-known investors: Soros Fund

    GestorLens profile
  • Centrus Energy

    LEU
    • 09:09 ETOtherSEC 8-K 8.01

      Other events

      From the filing
      On November 12, 2026, Centrus Energy Corp. issued a press release announcing that it had signed a contract with Oklo, Inc. to supply high-assay low-enriched uranium.

    On GestorLens

    • 4 concentrated managers (+1 this quarter)
    • 220 13F filers
    GestorLens profile
  • Moog

    MOG/A
    • 09:06 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: John Scannell may sell up to 3,000 shares (~$1.0 million, 0.09% of shares outstanding) on or about November 11, 2026.

    On GestorLens

    • 1 concentrated managers
    • 300 13F filers
    GestorLens profile
  • Rocket Companies

    RKT
    • 09:03 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      Bill Emerson resigns from the board. Adam Blitzer joins the board, effective November 16, 2026.

      Company headline: “Rocket Companies Appoints Datadog COO Adam Blitzer to Board of Directors”

      Also: Regulation FD disclosure

      From the filing
      On November 6, 2026, Bill Emerson, a Class I Director, provided notice of his resignation from the board of directors (the “Board”) of Rocket Companies, Inc. (the “Company”) effective immediately on such date.

    On GestorLens

    • 2 concentrated managers
    • 401 13F filers

    Well-known investors: ValueAct, Stanley Druckenmiller

    GestorLens profile
  • Terex

    TEX
    • 09:00 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      Patrick Carroll to retire as President.

      From the filing
      On November 6, 2026, Patrick Carroll, President, Environmental Solutions, one of Terex Corporation’s (the “Company”) business segments, notified the Company that he plans to retire from the Company on May 14, 2027.

    On GestorLens

    • 1 concentrated managers
    • 230 13F filers

    Well-known investors: Soros Fund

    GestorLens profile
  • Adaptive Biotechnologies

    ADPT
    • 08:56 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Chad Robins (officer) may sell up to 73,221 shares (~$2.2 million, 0.05% of shares outstanding) on or about November 11, 2026.

    On GestorLens

    • 154 13F filers

    Well-known investors: Viking Global

    GestorLens profile
  • NVIDIA

    NVDA
    • 08:52 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      Harvey C. Jones appointed Chair of the Board.

      Company headline: “NVIDIA Announces CEO Transition”

      From the filing
      On November 11, 2026, the Board appointed Harvey C. Jones, age 73, as Chair of the Board.

    On GestorLens

    • 109 concentrated managers (+4 this quarter)
    • 4,177 13F filers

    Well-known investors: Tiger Global, David Tepper, Soros Fund, Coatue

    GestorLens profile
  • Neptune Insurance Holdings

    NP
    • 08:51 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Matthew Duffy (officer, director) may sell up to 86,000 shares (~$2.4 million, 0.09% of shares outstanding) on or about November 11, 2026.

    On GestorLens

    • 49 13F filers

    Well-known investors: Soros Fund

    GestorLens profile
  • CAE

    CAE
    • 08:50 ETEarningsSEC 6-K

      Foreign issuer report

      Fiscal Q2 (ended September 30, 2026) results.

      Company headline: “CAE reports second quarter fiscal 2027 results”

      From the company's release
      We also made progress across each of our three transformation priorities: portfolio, capital discipline, and operational performance. In October, we announced an agreement to sell Flightscape to SITA for US$500 million.

    On GestorLens

    • 3 concentrated managers
    • 136 13F filers
    GestorLens profile
  • Roivant Sciences

    ROIV
    • 08:49 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Richard Pulik (officer, director) may sell up to 175,000 shares (~$7.3 million) on or about November 11, 2026.

    On GestorLens

    • 1 concentrated managers
    • 268 13F filers

    Well-known investors: David Einhorn, Viking Global

    GestorLens profile
  • Chevron

    CVX
    • 08:48 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Thomas Booth (officer) may sell up to 6,000 shares (~$1.3 million) on or about November 11, 2026.

    On GestorLens

    • 49 concentrated managers (-1 this quarter)
    • 3,045 13F filers

    Well-known investors: Berkshire Hathaway, Semper Augustus

    GestorLens profile
  • Borgwarner

    BWA
    • 08:47 ETDividends and buybacksSEC 8-K 7.01

      Dividend announcement

      Quarterly dividend of $0.17 per share, payable December 15, 2026 to shareholders of record on December 1, 2026.

      Company headline: “BORGWARNER DECLARES QUARTERLY DIVIDEND”

      From the filing
      On November 11, 2026, the Board of Directors of BorgWarner Inc. (the "Company") declared a quarterly cash dividend of $0.17 per share of the Company's common stock. The dividend is payable on December 15, 2026 to stockholders of record as of the close of business on December 1, 2026.

    On GestorLens

    • 3 concentrated managers (-1 this quarter)
    • 459 13F filers
    • 1 insider bought in 180 days ($500,639)

    Well-known investors: Soros Fund

    GestorLens profile
  • Veradermics

    MANE
    • 08:43 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Longitude Venture Partners V may sell up to 250,000 shares (~$37.6 million) on or about November 11, 2026.

    On GestorLens

    • 1 concentrated managers
    • 82 13F filers
    • 4 13D filings in the last year

    Well-known investors: Viking Global

    GestorLens profile
  • Corteva

    CTVA
    • 08:34 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q3 2026 (ended September 30, 2026) results.

      From the company's release
      News Release Corteva Reports Third-Quarter 2026 Results; Updates FY 2026 Outlook • Third-quarter results reflect strong new product sales growth and continued operational excellence, helping mitigate broader market headwinds • Pricing pressure was concentrated in North America and Latin America, reflecting an anticipated acetochlor headwind and competitive dynamics on molecules late in their lifecycle…

    On GestorLens

    • 4 concentrated managers (+1 this quarter)
    • 925 13F filers
    GestorLens profile
  • RadNet

    RDNT
    • 08:34 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Mital Patel (officer) may sell up to 44,661 shares (~$3.5 million, 0.06% of shares outstanding) on or about November 11, 2026.

    On GestorLens

    • 2 concentrated managers (+1 this quarter)
    • 190 13F filers

    Well-known investors: Soros Fund

    GestorLens profile
  • Micron Technology

    MU
    • 08:31 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Sumit Sadana (officer) may sell up to 14,000 shares (~$11.4 million) on or about November 11, 2026.

      Filed more than once with the SEC: shown once.

    On GestorLens

    • 42 concentrated managers (+3 this quarter)
    • 2,722 13F filers

    Well-known investors: David Tepper, Coatue, Soros Fund

    GestorLens profile
  • Talen Energy

    TLN2 filings
    • 08:30 ETOtherSEC 8-K 8.01

      Other events

      From the filing
      On November 9, 2026, certain indirect wholly owned subsidiaries of Talen Energy Corporation, a Delaware corporation (the “Company”), entered into ordinary course capacity sale transactions with an investment grade counterparty in PJM.
    • 07:47 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Edward T. Casulli (officer) may sell up to 3,303 shares (~$1.3 million) on or about November 11, 2026.

    On GestorLens

    • 7 concentrated managers (+1 this quarter)
    • 316 13F filers

    Well-known investors: Howard Marks, Soros Fund

    GestorLens profile
  • Advanced Micro Devices

    AMD
    • 08:29 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Nora Denzel (director) may sell up to 9,000 shares (~$5.1 million) on or about November 11, 2026.

    On GestorLens

    • 43 concentrated managers (+1 this quarter)
    • 2,787 13F filers

    Well-known investors: Dragoneer, Tiger Global, David Tepper, Stanley Druckenmiller and 2 more

    GestorLens profile
  • eBay

    EBAY
    • 08:27 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Cornelius Boone (officer) may sell up to 31,000 shares (~$3.8 million) on or about November 11, 2026.

    On GestorLens

    • 6 concentrated managers (-1 this quarter)
    • 786 13F filers
    • 1 13D filings in the last year
    GestorLens profile
  • Waste Connections

    WCN
    • 08:15 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Mary Anne Whitney (officer) may sell up to 5,500 shares (~$1.0 million) on or about November 11, 2026.

    On GestorLens

    • 7 concentrated managers
    • 442 13F filers

    Well-known investors: Gates Foundation Trust

    GestorLens profile
  • HubSpot

    HUBS
    • 08:08 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      Yamini Rangan steps down as President and Chief Executive Officer, effective November 12, 2026. Brian Halligan appointed President and CEO.

      Company headline: “HubSpot Announces Leadership Transition: Co-Founder Brian Halligan Returns as Chief Executive Officer to Lead a Refounding of the Company; Karen Burgess Named Next Chief Financial Officer”

      Also: Regulation FD disclosure

      From the filing
      On November 12, 2026, HubSpot, Inc. (the “Company”) announced that Yamini Rangan has stepped down as President and Chief Executive Officer (“CEO”) and has resigned as a member of the Company’s Board of Directors (the “Board”) effective as of November 12, 2026 (the “Effective Date”).

    On GestorLens

    • 359 13F filers
    • 1 insider bought in 180 days ($199,735)
    GestorLens profile
  • Avalyn Pharma

    AVLN
    • 08:08 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q3 2026 results.

      Company headline: “Avalyn Reports Third Quarter 2026 Financial Results and Recent Business Highlights”

      From the company's release
      Cash Position: Cash, cash equivalents, and marketable securities were $386.6 million as of September 30, 2026. The Company’s current cash, cash equivalents, and marketable securities are projected to be sufficient to fund operations into 2029.

    On GestorLens

    • 31 13F filers
    • 2 13D filings in the last year

    Well-known investors: Soros Fund

    GestorLens profile
  • The Western Union

    WU
    • 08:05 ETDeals and acquisitionsSEC 8-K 1.02

      Termination of a material agreement

      Company headline: “Western Union Announces Termination of Agreement to Acquire Intermex”

      Also: Regulation FD disclosure; Other events

      From the filing
      As previously announced, on August 10, 2025, The Western Union Company, a Delaware corporation (the “Company” or “Western Union”), entered into an Agreement and Plan of Merger (the “Merger Agreement”), by and among the Company, International Money Express, Inc., a Delaware corporation (“IMXI”), and Ivey Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of the Company (“Merger Sub”), providing for…

    On GestorLens

    • 3 concentrated managers
    • 277 13F filers
    GestorLens profile
  • Aktis Oncology

    AKTS
    • 08:05 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Company headline: “Aktis Oncology Reports Third-Quarter Financial Results and Highlights Clinical Trial Progress”

      From the company's release
      Third quarter 2026 financial results • Cash position: Cash, cash equivalents, and marketable securities were $492.9 million as of September 30, 2026, compared with $226.8 million as of December 31, 2025.

    On GestorLens

    • 38 13F filers
    • 2 13D filings in the last year

    Well-known investors: Soros Fund

    GestorLens profile
  • Aflac

    AFL
    • 08:04 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      Japan Post Holdings and 4 related filers updated their stake: 10.13% (50,121,329 shares) (passive, 13G) as of November 10, 2026.

      Filed by: Japan Post Holdings Co., Ltd.

    On GestorLens

    • 10 concentrated managers
    • 1,124 13F filers
    GestorLens profile
  • PVH

    PVH
    • 08:00 ETOtherSEC 8-K 2.05

      Exit or restructuring costs

      Restructuring plan: about 4% workforce reduction.

      From the filing
      The Company expects to reduce its global workforce by approximately 4%, primarily in non-consumer-facing positions, which is around 12% of its office-based associates.

    On GestorLens

    • 1 concentrated managers (+1 this quarter)
    • 225 13F filers
    • 1 insider bought in 180 days ($1M)

    Well-known investors: David Einhorn

    GestorLens profile
  • Snap-on

    SNA
    • 08:00 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Nicholas Pinchuk (director, officer) may sell up to 23,447 shares (~$8.8 million, 0.05% of shares outstanding) on or about November 11, 2026.

    On GestorLens

    • 3 concentrated managers
    • 663 13F filers
    GestorLens profile
  • Accelerant Holdings

    ARX
    • 08:00 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q3 2026 results: loss per share of $0.06 (adjusted: earnings of $0.18).

      Company headline: “Accelerant Announces Third Quarter 2026 Results”

      From the company's release
      Pre-tax loss of $1.6 million, net loss of $9.2 million, and net loss per diluted share of $0.06

    On GestorLens

    • 55 13F filers

    Well-known investors: Tiger Global

    GestorLens profile
  • MACOM Technology Solutions Holdings

    MTSI
    • 07:59 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Stephen Daly (director, officer) may sell up to 59,939 shares (~$13.6 million, 0.08% of shares outstanding) on or about November 11, 2026.

    On GestorLens

    • 1 concentrated managers
    • 340 13F filers
    GestorLens profile
  • SOPHiA GENETICS

    SOPH
    • 07:59 ET5%+ stakesSEC Schedule 13D/A

      Change in a 5%+ stake with activist intent

      Yair Chaim Schindel and 8 related filers updated their stake: 6.2% (5,318,023 shares) (active, 13D) as of November 10, 2026.

      Filed by: Schindel Yair Chaim

      From the filing
      On November 10, 2026, aMoon Edge sold an aggregate of 192,541 Ordinary Shares in a private block sale at a price of $7.70 per share for gross proceeds of approximately $1.48 million.

    On GestorLens

    • 1 concentrated managers
    • 33 13F filers
    • 2 insiders bought in 180 days ($377,388)

    Well-known investors: Akre Capital

    GestorLens profile
  • Palantir Technologies

    PLTR
    • 07:58 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Shyam Sankar (officer) may sell up to 84,680 shares (~$14.3 million) on or about November 11, 2026.

    On GestorLens

    • 26 concentrated managers (+3 this quarter)
    • 2,209 13F filers
    GestorLens profile
  • Hinge Health

    HNGE
    • 07:56 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Gabriel Mecklenburg may sell up to 200,000 shares (~$24.6 million, 0.29% of shares outstanding) on or about November 11, 2026.

    On GestorLens

    • 3 concentrated managers (+2 this quarter)
    • 170 13F filers
    GestorLens profile
  • Revolution Medicines

    RVMD
    • 07:56 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Jack Lee Anders (officer) may sell up to 35,750 shares (~$6.9 million) on or about November 11, 2026.

    On GestorLens

    • 1 concentrated managers
    • 405 13F filers

    Well-known investors: Stanley Druckenmiller

    GestorLens profile
  • Apollo Global Management

    APO

    On GestorLens

    • 5 concentrated managers (+1 this quarter)
    • 685 13F filers
    • 3 13D filings in the last year

    Well-known investors: Markel Group, Tiger Global, Soros Fund

    GestorLens profile
  • ERock

    EROC
    • 07:48 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q3 2026 results.

      Company headline: “ERock Reports Third Quarter 2026 Results”

      From the company's release
      Increased revenue nearly 4x quarter-over-quarter driving positive net income of $8.9MM and Adjusted EBITDA* of $12.6MM, due to increased generator production and installation activity.

    On GestorLens

    • 1 concentrated managers
    • 53 13F filers
    • 1 13D filings in the last year

    Well-known investors: Soros Fund, Dan Loeb

    GestorLens profile
  • Lamb Weston Holdings

    LW
    • 07:45 ETOtherSEC 8-K 8.01

      Other events

      From the filing
      As previously disclosed, Lamb Weston, Inc. (“Lamb Weston”), a wholly owned subsidiary of Lamb Weston Holdings, Inc. (the “Company”), and several other defendants have been named in a putative class action that was filed by private plaintiffs in the U.S. District Court for the District of Oregon…

    On GestorLens

    • 1 concentrated managers (-1 this quarter)
    • 327 13F filers

    Well-known investors: Starboard Value

    GestorLens profile
  • OR Royalties

    OR
    • 07:44 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      Bank of Montreal and 5 related filers reported a stake: 5.1% (9,505,669 shares) (passive, 13G) as of September 30, 2026.

      Filed by: BANK OF MONTREAL /CAN/

    On GestorLens

    • 4 concentrated managers
    • 135 13F filers
    GestorLens profile
  • News

    NWSA
    • 07:44 ETOtherSEC 8-K 8.01

      Other events

      From the company's release
      Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

    On GestorLens

    • 2 concentrated managers
    • 392 13F filers

    Well-known investors: Starboard Value

    GestorLens profile
  • Algonquin Power & Utilities

    AQN
    • 07:41 ETOtherSEC 6-K

      Foreign issuer report

      Company announcement.

      Company headline: “Algonquin Power & Utilities Corp. Announces Commencement of Consent Solicitations for Three Series of Subordinated Notes”

      From the company's release
      Algonquin Power & Utilities Corp. (TSX/NYSE: AQN) (“AQN”) today announced that it has commenced (i) solicitations of consents (the “U.S. Solicitations”) from holders of its outstanding 6.20% Fixed-to-Floating Subordinated Notes – Series 2019‑A due July 1, 2079 (NYSE: AQNB) (the “2019‑A Notes”) and its outstanding 4.750% Fixed-to-Fixed Reset Rate Junior Subordinated Notes Series 2022-B due January 18…

    On GestorLens

    • 1 concentrated managers
    • 110 13F filers
    • 1 13D filings in the last year

    Well-known investors: Starboard Value

    GestorLens profile
  • Zoom Communications

    ZM
    • 07:33 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      Norges Bank reported a stake: 5.15% (13,548,526 shares) (passive, 13G) as of September 30, 2026.

      Filed by: NORGES BANK

    On GestorLens

    • 2 concentrated managers
    • 496 13F filers
    GestorLens profile
  • Vivmark Residential

    VMRK
    • 07:33 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      Norges Bank updated its stake: 6.89% (53,396,865 shares) (passive, 13G) as of September 30, 2026.

      Filed by: NORGES BANK

    On GestorLens

    • 4 concentrated managers
    • 557 13F filers
    GestorLens profile
  • Tyler Technologies

    TYL
    • 07:33 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      Norges Bank updated its stake: 6.82% (2,792,269 shares) (passive, 13G) as of September 30, 2026.

      Filed by: NORGES BANK

    On GestorLens

    • 9 concentrated managers (+3 this quarter)
    • 450 13F filers

    Well-known investors: Markel Group

    GestorLens profile
  • Altimmune

    ALT
    • 07:33 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q3 2026 results.

      Company headline: “Altimmune Announces Third Quarter 2026 Financial Results and Business Update”

      From the company's release
      Altimmune Announces Third Quarter 2026 Financial Results and Business Update

    On GestorLens

    • 77 13F filers
    • 1 insider bought in 180 days ($44,250)

    Well-known investors: Viking Global

    GestorLens profile
  • Mid-america Apartment Communities

    MAA
    • 07:33 ET5%+ stakesSEC Schedule 13G

      New passive 5%+ stake

      Norges Bank reported a stake: 6.03% (6,997,545 shares) (passive, 13G) as of September 30, 2026.

      Filed by: NORGES BANK

    On GestorLens

    • 5 concentrated managers
    • 417 13F filers
    • 2 insiders bought in 180 days ($241,287)

    Well-known investors: Viking Global

    GestorLens profile
  • Federal Realty Investment Trust

    FRT
    • 07:33 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      Norges Bank updated its stake: 5.26% (4,574,308 shares) (passive, 13G) as of September 30, 2026.

      Filed by: NORGES BANK

    On GestorLens

    • 2 concentrated managers (-1 this quarter)
    • 347 13F filers
    GestorLens profile
  • Everest Group

    EG
    • 07:33 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      Norges Bank reports a 4.65% stake (1,783,871 shares), below 5% as of September 30, 2026.

      Filed by: NORGES BANK

    On GestorLens

    • 3 concentrated managers
    • 401 13F filers
    GestorLens profile
  • Kraft Heinz

    KHC
    • 07:32 ETOtherSEC 8-K 7.01

      Regulation FD disclosure

      From the company's release
      Kraft Heinz (NYSE: KHC) (“Kraft Heinz” or the “Company”) is hosting its 2026 Investor Day today, where senior management will outline the Company’s strategy to deliver sustainable, volume-led profitable growth.

    On GestorLens

    • 3 concentrated managers (-1 this quarter)
    • 699 13F filers
    • 1 13D filings in the last year

    Well-known investors: Berkshire Hathaway, Bruce Berkowitz, Gates Foundation Trust

    GestorLens profile
  • BridgeBio Pharma

    BBIO
    • 07:32 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      Farallon Capital Management and 15 related filers updated their stake: 7.3% (14,247,000 shares) (passive, 13G) as of September 30, 2026.

      Filed by: FARALLON CAPITAL MANAGEMENT, L.L.C.

    On GestorLens

    • 1 concentrated managers (+1 this quarter)
    • 233 13F filers
    • 2 13D filings in the last year

    Well-known investors: Viking Global

    GestorLens profile
  • Yesway

    YSWY
    • 07:30 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q3 2026 (ended September 30, 2026) results.

      Company headline: “Yesway, Inc. Reports Third Quarter 2026…”

      From the company's release
      1.9% year-over-year. Total inside merchandise sales increased 4.0% year-over-year, with a total inside merchandise margin of 35.1%.

    On GestorLens

    • 41 13F filers

    Well-known investors: Soros Fund

    GestorLens profile
  • Legence

    LGN
    • 07:23 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q3 2026 results: EPS of $1.15.

      Company headline: “Legence Reports Third Quarter 2026 Financial Results”

      From the company's release
      Net income attributable to Legence for the third quarter 2026 was $89.6 million, or $1.15 per diluted share, compared to a net loss attributable to Legence of $0.6 million for the third quarter 2025, or $(0.02) per diluted share.

    On GestorLens

    • 1 concentrated managers
    • 110 13F filers

    Well-known investors: Soros Fund

    GestorLens profile
  • flyExclusive

    FLYX
    • 07:17 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      From the company's release
      Q3 2026(1) Performance at a glance Improved SG&A operational leverage SG&A % of Revenue (2) Flight Hours per SG&A Headcount Revenue per SG&A Headcount Consolidated results of flyExclusive, Inc. for the three-month period ending September 30, 2026.

    On GestorLens

    • 34 13F filers
    • 3 13D filings in the last year

    Well-known investors: Dan Loeb

    GestorLens profile
  • DPC Holdings

    DPC
    • 07:15 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Company headline: “…Holdings Reports Record Third Quarter 2026 Results”

      From the filing
      On November 12, 2026, DPC Holdings PLC (the “Company”) issued a press release providing financial results for the second quarter ended September 27, 2026.

    On GestorLens

    • 35 13F filers

    Well-known investors: Soros Fund, Howard Marks, Viking Global

    GestorLens profile
  • SOLV Energy

    MWH
    • 07:14 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q3 2026 results.

      Company headline: “SOLV ENERGY REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS”

      From the company's release
      Revenue for the third quarter of 2026 increased 65% year over year to $1,242 million, bringing year to date revenue to $2,870 million, or an increase of 69% year over year.

    On GestorLens

    • 1 concentrated managers (-1 this quarter)
    • 93 13F filers

    Well-known investors: Soros Fund

    GestorLens profile
  • Brookfield

    BN
    • 07:10 ETEarningsSEC 6-K

      Foreign issuer report

      Company announcement.

      Company headline: “Brookfield Corporation Reports 16% Increase in Earnings”

      From the company's release
      Nick Goodman, President of Brookfield Corporation, said, “We delivered strong financial results in the third quarter. Our asset management business raised $25 billion, wealth solutions delivered 22% earnings growth, and our operating businesses continued to generate resilient cash flows.”

    On GestorLens

    • 22 concentrated managers (+3 this quarter)
    • 536 13F filers

    Well-known investors: Markel Group, Bill Ackman, Akre Capital, Lone Pine

    GestorLens profile
  • JD.com

    JD
    • 07:08 ETOtherSEC 6-K

      Foreign issuer report

      Company announcement.

      Company headline: “JD.com Completes Voluntary Public Takeover Offer of CECONOMY”

      From the company's release
      JD.com, Inc. (“JD.com” or the “Company”) (NASDAQ: JD and HKEX: 9618 (HKD counter) and 89618 (RMB counter)), a leading supply chain-based technology and service provider, today announced the completion of its previously announced voluntary public takeover offer for CECONOMY AG (“CECONOMY”) (XETRA: CEC), acquiring 59.8% of the share capital and voting rights of CECONOMY with total consideration of EUR 1,335 million.

    On GestorLens

    • 2 concentrated managers (-1 this quarter)
    • 219 13F filers

    Well-known investors: Tiger Global

    GestorLens profile
  • Applied Aerospace & Defense

    AADX
    • 07:07 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q3 2026 (ended September 30, 2026) results: revenue of $182.1 million; EPS of $0.18.

      Company headline: “Applied Aerospace & Defense Reports Third Quarter 2026 Financial Results”

      From the company's release
      "We delivered record revenue of $182.1 million and Adjusted EBITDA of $39.7 million.

    On GestorLens

    • 59 13F filers

    Well-known investors: Soros Fund

    GestorLens profile
  • Mobility Global

    MBGL
    • 07:03 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q3 2026 (ended September 30, 2026) results: revenue of $478 million.

      Company headline: “MOBILITY GLOBAL REPORTS THIRD QUARTER 2026 FINANCIAL RESULTS”

      From the company's release
      Total revenue of $478 million, increased by 7.4%

    On GestorLens

    • 3 concentrated managers (+3 this quarter)
    • 489 13F filers
    • 1 insider bought in 180 days ($980,550)

    Well-known investors: Markel Group

    GestorLens profile
  • Thomson Reuters

    TRI2 filings
    • 07:01 ETDividends and buybacksSEC 6-K

      Foreign issuer report

      Company announcement.

      Company headline: “Thomson Reuters Announces $500 Million Share Repurchase Program and New Normal Course Issuer Bid”

      From the company's release
      Thomson Reuters (TSX/Nasdaq: TRI), a global content and technology company, today announced that it plans to repurchase up to $500 million of its shares. Purchases of shares will occur under a new normal course issuer bid (NCIB) that has been approved by the Toronto Stock Exchange (TSX).
    • 06:15 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: The Woodbridge may sell up to 2,000,000 shares (~$217.7 million, 0.46% of shares outstanding) on or about November 12, 2026.

    On GestorLens

    • 3 concentrated managers
    • 266 13F filers
    GestorLens profile
  • D-Wave Quantum

    QBTS
    • 07:00 ETOtherSEC 8-K 7.01

      Regulation FD disclosure

      Company headline: “D-Wave Named a Market Shaper as of November 2026 in the Gartner® Emerging Market Quadrant™ for Quantum Computing – Established Vendors”

      From the company's release
      D-Wave Quantum Inc. (NASDAQ: QBTS) (“D-Wave” or the “Company”), the only dual-platform quantum computing company providing both annealing and gate-model systems, software, and services, today announced it has been recognized as a Market Shaper in the Gartner® Emerging Market Quadrant for Quantum Computing - Established Vendors as of November 2026…

    On GestorLens

    • 3 concentrated managers
    • 318 13F filers
    GestorLens profile
  • Henry Schein

    HSIC
    • 07:00 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      Artisan Partners Asset Management and 3 related filers report a 4.8% stake (5,505,566 shares), below 5% as of September 30, 2026.

      Filed by: Artisan Partners Limited Partnership

    On GestorLens

    • 2 concentrated managers
    • 345 13F filers
    • 1 13D filings in the last year

    Well-known investors: David Einhorn

    GestorLens profile
  • State Street

    STT
    • 06:59 ETPlanned insider salesSEC Form 144

      Notice of proposed sale (Form 144)

      Notice of proposed sale: Kathryn M Horgan (officer) may sell up to 6,437 shares (~$1.1 million) on or about November 11, 2026.

    On GestorLens

    • 6 concentrated managers (+1 this quarter)
    • 819 13F filers
    GestorLens profile
  • Spectrum Brands Holdings

    SPB2 filings
    • 06:54 ETOtherSEC 8-K 8.01

      Other events

      Company headline: “Empower Brands Issues Open Letter to Helen of Troy Shareholders”

      From the company's release
      Empower Brands Holdings Group, LLC (“Empower Brands”), the Home & Personal Care business jointly owned by Spectrum Brands Holdings, Inc. (“Spectrum Brands”) (NYSE: SPB) and funds managed by Oaktree Capital Management, L.P.…
    • 06:46 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Fiscal Q4 2026 (ended September 30, 2026) results.

      Company headline: “Spectrum Brands Holdings Reports Fiscal 2026 Fourth Quarter and Full Year Results”

      From the company's release
      Net sales decreased 2.8% with a decrease in organic net sales of 3.1%, which excludes the impact of $2.7 million of favorable foreign exchange rates. The net sales decline was primarily driven by Home & Garden, where unfavorable weather conditions and elevated retailer inventory levels adversely impacted replenishment orders.

    On GestorLens

    • 1 concentrated managers
    • 165 13F filers
    • 1 insider bought in 180 days ($182,125)

    Well-known investors: David Einhorn

    GestorLens profile
  • Pharvaris

    PHVS
    • 06:51 ETEarningsSEC 6-K

      Foreign issuer report

      Company announcement.

      Company headline: “Pharvaris Reports Third Quarter 2026 Financial Results and Provides Business Update”

      From the company's release
      CHAPTER-3 (NCT06669754) met the primary endpoint and all secondary efficacy endpoints with statistical significance. Outcomes from CHAPTER-3, a pivotal global Phase 3 study of investigational deucrictibant XR for the prophylaxis against angioedema attacks in adults and adolescents (12 years and older) with HAE, confirmed the potential deucrictibant’s differentiated profile for the prophylaxis of HAE attacks.

    On GestorLens

    • 31 13F filers

    Well-known investors: Viking Global

    GestorLens profile
  • MP Materials

    MP3 filings
    • 06:50 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      Michael Stuart Rosenthal (Chief Operating Officer) bought 32,000 shares for $1.2 million (avg. $36.72).

    • 06:41 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      Randall J Weisenburger (director) bought 55,000 shares for $2.0 million (avg. $36.00).

    • 06:37 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      Ryan Corbett (Chief Financial Officer) bought 5,476 shares for $198,516 (avg. $36.25).

    On GestorLens

    • 1 concentrated managers (-1 this quarter)
    • 414 13F filers
    • 1 insider bought in 180 days ($1.5M)
    • 1 13D filings in the last year
    GestorLens profile
  • Figure Technology Solutions

    FIGR
    • 06:47 ETEarningsSEC 8-K 1.01

      Entry into a material agreement

      Also: Results of operations and financial condition; New direct financial obligation

      From the filing
      On November 10, 2026 (the “Closing Date”), Figure Technology Solutions, Inc., a Nevada corporation (the “Company”), entered into a Credit and Guarantee Agreement (the “Credit Agreement”), among the Company, as borrower, certain of the Company's domestic, wholly-owned subsidiaries, as guarantors (the “Guarantors”), JPMorgan Chase Bank, N.A., as administrative agent (the “Agent”), and certain other parties thereto.

    On GestorLens

    • 3 concentrated managers
    • 168 13F filers

    Well-known investors: Soros Fund

    GestorLens profile
  • GFL Environmental

    GFL
    • 06:46 ETOtherSEC 6-K

      Foreign issuer report

      Company announcement.

      Company headline: “GFL Environmental Announces Issuance of 6,219,896…”

      From the company's release
      GFL Environmental Inc. (NYSE: GFL) (TSX: GFL) (“GFL” or the “Company”) today announced that HPS Investment Partners, LLC (“HPS”), on behalf of the holders of the Company’s Series A perpetual convertible preferred shares (“Series A Preferred Shares”), has provided notice of conversion of 4,867,006 Series A Preferred Shares for 6,219,896 subordinate voting shares.

    On GestorLens

    • 6 concentrated managers (+3 this quarter)
    • 202 13F filers

    Well-known investors: Soros Fund

    GestorLens profile
  • T1 Energy

    TE
    • 06:37 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q3 2026 results: loss per share of $0.14.

      Company headline: “…Energy Reports Third Quarter 2026 Results”

      Also: Regulation FD disclosure

      From the company's release
      Energy reported a net loss attributable to common stockholders for the third quarter of 2026 of $41.6 million, or $(0.14) per share compared to a net loss of $140.8 million, or $(0.87) per share for the third quarter of 2025.

    On GestorLens

    • 143 13F filers
    • 3 13D filings in the last year

    Well-known investors: Soros Fund

    GestorLens profile
  • Forgent Power Solutions

    FPS
    • 06:33 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Fiscal Q1 (ended September 30, 2026) results: revenue of $479 million; EPS of $0.18 (adjusted: $0.24).

      Company headline: “Forgent Reports Fiscal First Quarter 2027 Results Above High End of Guidance; Raises Full-Year Outlook on Strong Commercial and Operational Execution”

      From the company's release
      Revenues of $479 million, an increase of 69% year-over-year

    On GestorLens

    • 1 concentrated managers
    • 201 13F filers

    Well-known investors: Coatue, Soros Fund

    GestorLens profile
  • General Dynamics

    GD
    • 06:28 ET5%+ stakesSEC Schedule 13G/A

      Change in a passive 5%+ stake

      Newport Trust reports a 4.88% stake (13,206,657 shares), below 5% as of September 30, 2026.

      Filed by: Newport Trust Company, LLC

    On GestorLens

    • 13 concentrated managers (-1 this quarter)
    • 1,489 13F filers
    • 1 13D filings in the last year

    Well-known investors: Markel Group

    GestorLens profile
  • Range Resources

    RRC
    • 06:18 ETMergers and tender offersSEC 425

      Communication about a merger or acquisition

      EQT filed a communication about its deal with Range Resources.

    On GestorLens

    • 3 concentrated managers (+1 this quarter)
    • 302 13F filers
    GestorLens profile
  • Galapagos

    LKFT
    • 06:15 ETEarningsSEC 6-K

      Foreign issuer report

      Company announcement.

      Company headline: “Lakefront Biotherapeutics Reports Nine Months 2026 Financial Results and Provides Business Update”

      From the company's release
      Year-end 2026 guidance for cash and financial investments of at least €2B, including initiating a second €50M share repurchase program Mechelen, Belgium; November 11, 2026, 22.01 CET; regulated information – Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) today reported its financial results for the first nine months of 2026 and provided a business update.

    On GestorLens

    • 1 concentrated managers (+1 this quarter)
    • 40 13F filers

    Well-known investors: David Einhorn

    GestorLens profile
  • Tetra Tech

    TTEK
    • 06:08 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Fiscal Q4 (ended September 27, 2026) results.

      Company headline: “Tetra Tech Reports Strong Fourth Quarter and Fiscal Year 2026 Results”

      Also: Other events

      From the company's release
      Revenue and revenue, net of subcontractor costs (net revenue)1, in the fourth quarter totaled $1.34 billion and $1.15 billion, respectively.

    On GestorLens

    • 3 concentrated managers (+1 this quarter)
    • 326 13F filers
    GestorLens profile
  • WEX

    WEX
    • 06:07 ETDeals and acquisitionsSEC 8-K 1.01

      Entry into a material agreement

      Also: New direct financial obligation

      From the filing
      From time to time, certain parties to the Amended Credit Agreement, and affiliates of those parties, have provided, and may in the future provide banking, investment banking, and other financial services to the Company or the Company’s affiliates.

    On GestorLens

    • 4 concentrated managers
    • 235 13F filers
    • 1 insider bought in 180 days ($214,425)
    • 1 13D filings in the last year
    GestorLens profile
  • EnerSys

    ENS
    • 06:06 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Fiscal Q2 2027 results: EPS of $2.42.

      Company headline: “RESULTS FOR THE SECOND QUARTER FISCAL 2027”

      Also: Other events

      From the company's release
      Delivers Gross Margin of 29.9% or 25.2% ex IRC 45X (1) and Diluted EPS of $2.42, +34% ($1.22, +61% ex IRC 45X(1))

    On GestorLens

    • 2 concentrated managers
    • 303 13F filers
    • 1 insider bought in 180 days ($24,675)
    GestorLens profile
  • Invitation Homes

    INVH
    • 06:05 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      M. Colin Connolly joins the board, effective November 13, 2026.

      Company headline: “Invitation Homes Announces Addition of M. Colin Connolly to Board of Directors”

      Also: Regulation FD disclosure

      From the filing
      (d) On November 9, 2026, the Board of Directors (the “Board”) of Invitation Homes Inc. (the “Company”) increased the size of the Board from 9 to 10 members and appointed M. Colin Connolly as a director of the Board, effective as of November 13, 2026, with a term expiring at the Company’s 2027 annual meeting of stockholders.

    On GestorLens

    • 2 concentrated managers
    • 340 13F filers
    GestorLens profile
  • X-Energy

    XE
    • 06:04 ETEarningsSEC 8-K 2.02

      Results of operations and financial condition

      Q3 2026 results.

      Company headline: “X-energy Reports Third Quarter 2026 Results”

      From the company's release
      Total revenues and grant income in the three months ended September 30, 2026 were $66.3 million, including $51.5 million of services revenue and $14.8 million of grant income.

    On GestorLens

    • 2 concentrated managers
    • 127 13F filers

    Well-known investors: Soros Fund, Viking Global

    GestorLens profile
  • Public Storage

    PSA
    • 06:03 ETLeadership changesSEC 8-K 5.02

      Departure or appointment of directors or officers

      From the filing
      On November 11, 2026, Public Storage (the “Company”) and Natalia N. Johnson, the Company’s President, Chief Digital & Transformation Officer, agreed that Ms. Johnson will leave the Company, effective January 31, 2027.

    On GestorLens

    • 8 concentrated managers
    • 704 13F filers
    GestorLens profile
  • GDS Holdings

    GDS
    • 06:03 ETOtherSEC 6-K

      Foreign issuer report

      Company announcement.

      Company headline: “GDS to Report Third Quarter 2026 Financial Results Before the Open of the U.S. Market on November 25, 2026”

      From the company's release
      The Company’s management will host an earnings conference call at 7:00 AM U.S. Eastern Time on Wednesday, November 25, 2026 (8:00 PM Hong Kong Time on the same day).

    On GestorLens

    • 1 concentrated managers
    • 84 13F filers

    Well-known investors: Seth Klarman

    GestorLens profile
  • Coherent

    COHR2 filings
    • 06:02 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      James Robert Anderson (CEO) bought 5,000 shares for $997,400 (avg. $199.48).

    • 06:01 ETInsider buyingSEC Form 4 (P)

      Open-market purchase by an insider

      Enrico Digirolomo (director) bought 1,000 shares for $222,885 (avg. $222.89).

    On GestorLens

    • 15 concentrated managers (+3 this quarter)
    • 752 13F filers
    • 1 13D filings in the last year
    GestorLens profile
  • RLI

    RLI
    • 06:01 ETDividends and buybacksSEC 8-K 8.01

      Dividend announcement

      Special dividend of $3.00 per share, payable December 7, 2026 to shareholders of record on November 30, 2026.

      Company headline: “RLI DECLARES REGULAR & SPECIAL DIVIDEND”

      From the company's release
      RLI Corp. (NYSE: RLI) announced today its Board of Directors has declared a special cash dividend of $3.00 per share of common stock, which is expected to total approximately $275 million, and a regular quarterly cash dividend of $0.18 per share. Both dividends are payable on December 7, 2026, to shareholders of record as of November 30, 2026.

    On GestorLens

    • 2 concentrated managers
    • 252 13F filers
    • 4 insiders bought in 180 days ($1M)

    Well-known investors: Markel Group

    GestorLens profile

What each filing is

Form 8-K
The current report of a material event: the company has 4 business days to file it. Each item is a type of event; the label is the one the company chose.
Schedule 13D
Whoever crosses 5% of the shares intending to influence the company (board seats, a sale, a change of strategy) files a 13D within 5 business days. It is the typical activist filing. More in the glossary
Schedule 13G
The form filed by whoever crosses 5% of a company's shares as a passive investor, with no intent to influence it. Mostly filed by large asset managers and index funds. More in the glossary
Form 4
The form directors, officers and 10%+ shareholders use to report every purchase or sale of their own company's shares, within 2 business days. Only open-market purchases (code P) are shown here. More in the glossary
Form 144
The notice an insider or major shareholder files BEFORE selling restricted shares, when the sale exceeds 5,000 shares or $50,000 in three months. It states how many shares they plan to sell and from when: it does not confirm the sale happened (that comes later in a Form 4).

Everything comes from SEC EDGAR, the system where companies file their documents with the SEC.

Source: SEC EDGAR. Text is built with fixed rules from each filing, without artificial intelligence; quotes stay in their original language. Times are New York (ET), with your browser's time next to them.

Filings are grouped by the New York date and time at which the SEC received each document.

Not investment advice. A notice of proposed sale (Form 144) does not confirm that a sale took place.

Follow the investors you care about

Build your list and get what they report by email, if you turn it on. Free, no credit card.

Create free account